8 research outputs found

    Additional file 3: of Previously claimed male germline stem cells from porcine testis are actually progenitor Leydig cells

    No full text
    Figure S1. Enrichment of porcine male germline stem cell (mGSCs). (a) The testicular suspension contained several cell types. (b) Testicular fibroblast cells (TFCs) were removed by differential attachment technique. (c) The unattached cells underwent density gradient centrifuging to remove the leukomonocytes (LYMs) and cell debris (d) and red blood cells (RBCs) (e), and to retain mGSCs (f). (JPG 699 kb

    Additional file 5: of Previously claimed male germline stem cells from porcine testis are actually progenitor Leydig cells

    No full text
    Figure S3. Cell cycle assay of putative porcine male germline stem cell (mGSCs). Cell cycle analyses at cell culture days 3, 5, and 7 revealed that only a small percentage of the putative mGSCs entered the S and G2 cell division phases. Meanwhile, part of putative mGSCs underwent apoptosis detected by analysis of apoptosis at day 7 of cell culture. (JPG 285 kb

    Additional file 4: of Previously claimed male germline stem cells from porcine testis are actually progenitor Leydig cells

    No full text
    Figure S2. Immunolocalization of VASA and NANOG proteins in the testis of 5-day-old piglet. Immunohistochemistry analysis showed that the reproduction-associated marker VASA localized to the basement membrane of seminiferous tubules, whereas the pluripotent factor NANOG was expressed in the interstitial space and seminiferous tubules. (JPG 442 kb

    Additional file 10: of Previously claimed male germline stem cells from porcine testis are actually progenitor Leydig cells

    No full text
    Figure S8. Induction of C2 clusters differentiation into mature adult Leydig cells (ALCs). The C2 clusters began to differentiate into fibroblast cells at day 1 (a), became smaller from days 3 to 6 (b, c), and had disappeared by day 9 (d) The C2 clusters were fully differentiated into ALCs by day 12 (e), with abundant mature ALCs observed by day 15 (f). (JPG 558 kb

    Supplemental Material, Table_S1_Information_of_104_ESCC_patients - High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC

    No full text
    <p>Supplemental Material, Table_S1_Information_of_104_ESCC_patients for High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC by Jie Yang, Pengzhou Kong, Jian Yang, Zhiwu Jia, Xiaoling Hu, Zianyi Wang, Heyang Cui, Yanghui Bi, Yu Qian, Hongyi Li, Fang Wang, Bin Yang, Ting Yan, Yanchun Ma, Ling Zhang, Caixia Cheng, Bin Song, Yaoping Li, Enwei Xu, Haiyan Liu, Wei Gao, Juan Wang, Yiqian Liu, Yuanfang Zhai, Lu Chang, Yi Wang, Yingchun Zhang, Ruyi Shi, Jing Liu, Qi Wang, Xiaolong Cheng, and Yongping Cui in Technology in Cancer Research & Treatment</p

    Supplemental Material, Table_S2_PH-assumption_tests_of_different_variables - High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC

    No full text
    <p>Supplemental Material, Table_S2_PH-assumption_tests_of_different_variables for High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC by Jie Yang, Pengzhou Kong, Jian Yang, Zhiwu Jia, Xiaoling Hu, Zianyi Wang, Heyang Cui, Yanghui Bi, Yu Qian, Hongyi Li, Fang Wang, Bin Yang, Ting Yan, Yanchun Ma, Ling Zhang, Caixia Cheng, Bin Song, Yaoping Li, Enwei Xu, Haiyan Liu, Wei Gao, Juan Wang, Yiqian Liu, Yuanfang Zhai, Lu Chang, Yi Wang, Yingchun Zhang, Ruyi Shi, Jing Liu, Qi Wang, Xiaolong Cheng, and Yongping Cui in Technology in Cancer Research & Treatment</p
    corecore